Skip to content

Clinical trials

Terminated Uterine Cervical Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Status: Terminated Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20211
20224
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shenzhen Geno-Immune Medical Institute2
Evopoint Biosciences Inc.1
Qilu Pharmaceutical Co., Ltd.1
Shanghai Bovax Biotechnology Co., Ltd.1
Shanghai Junshi Bioscience Co., Ltd.1
Sun Yat-Sen University Cancer Center1
Sun Yat-sen University1
Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
TCRCure Biopharma Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms10
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Condylomata Acuminata1
Esophageal Squamous Cell Carcinoma1
Liver Neoplasms1
Prostatic Neoplasms1
Small Cell Lung Carcinoma1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.